Hiddo Lambers Heerspink
Hiddo Lambers Heerspink
確認したメール アドレス: umcg.nl
タイトル
引用先
引用先
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
RT Gansevoort, R Correa-Rotter, BR Hemmelgarn, TH Jafar, ...
The Lancet 382 (9889), 339-352, 2013
11182013
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
8712019
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
CS Fox, K Matsushita, M Woodward, HJG Bilo, J Chalmers, ...
The Lancet 380 (9854), 1662-1673, 2012
6682012
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
D De Zeeuw, T Akizawa, P Audhya, GL Bakris, M Chin, H Christ-Schmidt, ...
New England Journal of Medicine 369 (26), 2492-2503, 2013
6342013
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease …
BC Astor, K Matsushita, RT Gansevoort, M Van Der Velde, M Woodward, ...
Kidney international 79 (12), 1331-1340, 2011
5422011
Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications
HJL Heerspink, BA Perkins, DH Fitchett, M Husain, DZI Cherney
Circulation 134 (10), 752-772, 2016
5032016
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
HJL Heerspink, T Ninomiya, S Zoungas, D de Zeeuw, DE Grobbee, ...
The Lancet 373 (9668), 1009-1015, 2009
4562009
Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes
HJ Lambers Heerspink, D De Zeeuw, L Wie, B Leslie, J List
Diabetes, Obesity and Metabolism 15 (9), 853-862, 2013
4502013
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ...
The Lancet 390 (10105), 1888-1917, 2017
3152017
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
KS Vimaleswaran, A Cavadino, DJ Berry, R Jorde, AK Dieffenbach, C Lu, ...
The lancet Diabetes & endocrinology 2 (9), 719-729, 2014
2852014
Dietary salt intake and mortality in patients with type 2 diabetes
EI Ekinci, S Clarke, MC Thomas, JL Moran, K Cheong, RJ MacIsaac, ...
Diabetes care 34 (3), 703-709, 2011
2832011
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised …
MCJ Slagman, F Waanders, MH Hemmelder, AJ Woittiez, WMT Janssen, ...
Bmj 343, d4366, 2011
2312011
First morning voids are more reliable than spot urine samples to assess microalbuminuria
EC Witte, HJL Heerspink, D de Zeeuw, SJL Bakker, PE de Jong, ...
Journal of the American Society of Nephrology 20 (2), 436-443, 2009
2292009
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
FA Holtkamp, D De Zeeuw, MC Thomas, ME Cooper, PA De Graeff, ...
Kidney international 80 (3), 282-287, 2011
2242011
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of …
S Czernichow, A Zanchetti, F Turnbull, F Barzi, T Ninomiya, AP Kengne, ...
Journal of hypertension 29 (1), 4-16, 2011
216*2011
Canagliflozin slows progression of renal function decline independently of glycemic effects
HJL Heerspink, M Desai, M Jardine, D Balis, G Meininger, V Perkovic
Journal of the American Society of Nephrology 28 (1), 368-375, 2017
2142017
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
L Tonneijck, MHA Muskiet, MM Smits, EJ Van Bommel, HJL Heerspink, ...
Journal of the American Society of Nephrology 28 (4), 1023-1039, 2017
2102017
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers
HJL Heerspink, FA Holtkamp, HH Parving, GJ Navis, JB Lewis, E Ritz, ...
Kidney international 82 (3), 330-337, 2012
2072012
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality
HJ Lambers Heerspink, AH Brantsma, D de Zeeuw, SJL Bakker, ...
American journal of epidemiology 168 (8), 897-905, 2008
2072008
Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis
N Tangri, ME Grams, AS Levey, J Coresh, LJ Appel, BC Astor, G Chodick, ...
Jama 315 (2), 164-174, 2016
1962016
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20